While the donor screening and testing requirements for FDA 351 cellular products have been thoroughly discussed and presented in multiple public forums, the private cord blood bank industry and related peripheral blood centers have not had the equal opportunity to understand these requirements. This topic is intended to educate cellular therapy facilities dealing with privately cord blood intended for related family members and for donor center facilities handling 1st and 2nd degree peripheral blood collections. Common screening tools will be demonstrated and provided to the audience. The audience will have the opportunity to work through various eligibility scenarios.